These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12677780)

  • 1. [Cardiovascular events in chronic advanced renal insufficiency. Current concepts].
    Zoccali C
    Recenti Prog Med; 2003 Mar; 94(3):125-30. PubMed ID: 12677780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional and emerging cardiovascular risk factors in end-stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G
    Kidney Int Suppl; 2003 Jun; (85):S105-10. PubMed ID: 12753278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal insufficiency is an important cardiovascular risk factor].
    Pérez Flores I; Luño J
    Nefrologia; 2002; 22(4):306-9. PubMed ID: 12369120
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy].
    Cases A; Vera M; López Gómez JM
    Nefrologia; 2002; 22 Suppl 1():68-74. PubMed ID: 11987673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?
    Kielstein JT; Zoccali C
    Am J Kidney Dis; 2005 Aug; 46(2):186-202. PubMed ID: 16112037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial damage, asymmetric dimethylarginine and cardiovascular risk in end-stage renal disease.
    Zoccali C
    Blood Purif; 2002; 20(5):469-72. PubMed ID: 12207095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular disease after renal transplantation].
    Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
    G Ital Nefrol; 2004; 21 Suppl 26():S53-66. PubMed ID: 15732047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel cardiovascular risk factors in end-stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G
    J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S77-80. PubMed ID: 14684678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
    Schiel R; Franke S; Busch M; Müller A; Fleck C; Müller UA; Braun A; Stein G
    Eur J Med Res; 2003 Jul; 8(7):283-91. PubMed ID: 12911864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical epidemiology of major nontraditional risk factors in peritoneal dialysis patients.
    Zoccali C; Enia G; Tripepi G; Panuccio V; Mallamaci F
    Perit Dial Int; 2005 Feb; 25 Suppl 3():S84-7. PubMed ID: 16048265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep disordered breathing in patients with chronic kidney disease.
    Mavanur M; Sanders M; Unruh M
    Indian J Med Res; 2010 Feb; 131():277-84. PubMed ID: 20308753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocturnal hypoxemia: a neglected cardiovascular risk factor in end-stage renal disease?
    Zoccali C; Mallamaci F; Tripepi G
    Blood Purif; 2002; 20(1):120-3. PubMed ID: 11803169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease in patients with chronic kidney disease. A clinical review.
    Kaisar M; Isbel N; Johnson DW
    Minerva Urol Nefrol; 2007 Sep; 59(3):281-97. PubMed ID: 17912225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer paradigms in renal replacement therapy: will they alter cardiovascular outcomes?
    Kundhal K; Pierratos A; Chan CT
    Cardiol Clin; 2005 Aug; 23(3):385-91. PubMed ID: 16084286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney disease as an independent risk factor for cardiovascular events.
    Kumar J; Shah SV
    J Ren Nutr; 2005 Jan; 15(1):99-104. PubMed ID: 15648016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients?
    Fleischmann EH; Bower JD; Salahudeen AK
    Clin Nephrol; 2001 Sep; 56(3):221-30. PubMed ID: 11597037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure in patients with chronic kidney disease.
    Lisowska A; Musiał WJ
    Rocz Akad Med Bialymst; 2004; 49():162-5. PubMed ID: 15631334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move.
    Zoccali C
    J Hypertens; 2006 Apr; 24(4):611-9. PubMed ID: 16531785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular mortality and morbidity in dialysis patients.
    Eknoyan G
    Miner Electrolyte Metab; 1999; 25(1-2):100-4. PubMed ID: 10207269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.